comparemela.com

Latest Breaking News On - Cancer australia collaborative research scheme pd - Page 1 : comparemela.com

Research grant to advance ovarian cancer treatment

Research grant to advance ovarian cancer treatment
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Grant Boosts Advancement in Ovarian Cancer Treatment

Grant Boosts Advancement in Ovarian Cancer Treatment
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Mater Researcher Secures Funding Boost for Lymphoma Studies

Mater Researcher Secures Funding Boost for Lymphoma Studies
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Roche leads industry sponsored oncology trials in Australia, says GlobalData

Search jobs Roche leads industry sponsored oncology trials in Australia, says GlobalData Australia has the highest age-standardized incidence rate for all cancers in the world and one of the countries with substantial cancer screening programs. Against this backdrop, several pharma companies are conducting clinical trials related to cancer drugs in the country. Among these, Roche continues to be a key player with the highest number of clinical trials in oncology indications, says GlobalData, a leading data and analytics company.   Ms. Sasmitha Sahu, Pharma Analyst at GlobalData, comments: “Despite high incidence rates, mortality rate is low in Australia due to early and extensive screening. Owing to the government’s greater focus on managing cancer, patients can gain access to good diagnostic facilities, healthcare and novel cancer therapies. Participation in clinical trials ensures early access to unapproved novel therapies.”  

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.